Global mRNA Vaccines & Therapeutics Market 2022-2028
mRNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to treat a wide variety of diseases with high unmet medical needs. The global mRNA vaccines & therapeutics market market is projected to decline by USD 34 million by 2028, according to a new report by Gen Consulting Company. It is anticipated to contract at a CAGR of -13.6 percent during the forecast period.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global mRNA vaccines & therapeutics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the mRNA vaccines & therapeutics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, type, disease, and region. The global market for mRNA vaccines & therapeutics can be segmented by product: mRNA vaccines, mRNA therapies. In 2021, the mRNA vaccines segment made up the largest share of revenue generated by the mRNA vaccines & therapeutics market. MRNA vaccines & therapeutics market is further segmented by type: nucleoside-modified mRNA (modRNA), self-amplifying mRNA (saRNA), unmodified mRNA. Based on disease, the mRNA vaccines & therapeutics market is segmented into: cardiometabolic diseases (CMDs), infectious diseases, oncology, rare diseases, respiratory diseases, others. On the basis of region, the mRNA vaccines & therapeutics market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook